0914 GMT - CVS Group's disposal of its crematorium division helps simplify the company's structure and sheds a business unit that provides a minor contribution to earnings, Davy Research analyst Colin Grant says. The analyst adds in a research note that the division can be considered non-core. "Overall, we view this disposal as opportunistic and attractive," Grant says. At a sale price of 42.4 million pounds, the disposal underscores the undervaluation of the rest of the company, the analyst says. The company expects to post a one-off 32.0 million pounds gain in its year-end account from the sale. CVS Group's shares trade 2.4% higher at 1,030 pence. (pierre.bertrand@wsj.com)
(END) Dow Jones Newswires
April 24, 2025 05:14 ET (09:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.